GPS Wealth Strategies Group’s Inovio Pharmaceuticals INO Stock Holding History

GPS Wealth Strategies Group’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$7	Hold	4	–	–	﹤0.01%	582
2025 Q3	$9	Hold	4	–	–	﹤0.01%	1659
2025 Q2	$8	Hold	4	–	–	﹤0.01%	1630
2025 Q1	$7	Hold	4	–	–	﹤0.01%	1511
2024 Q4	$7	Hold	4	–	–	﹤0.01%	1373
2024 Q3	$23	Hold	4	–	–	﹤0.01%	1384
2024 Q2	$32	Hold	4	–	–	﹤0.01%	1347
2024 Q1	$56	Hold	4	–	–	﹤0.01%	1236
2023 Q4	$26	Hold	4	–	–	﹤0.01%	1236
2023 Q3	$19	Hold	4	–	–	﹤0.01%	1274
2023 Q2	$22	Hold	4	–	–	﹤0.01%	1235
2023 Q1	$41	Buy	+4	New	+$68	﹤0.01%	1245
2022 Q4	–	Sell	-4	Closed	–	–	590
2022 Q3	$0	Hold	4	–	–	﹤0.01%	1156
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1144
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1082
2021 Q4	$0	Hold	4	–	–	﹤0.01%	1088
2021 Q3	$0	Sell	4 -17	-81%	-$1.71K	﹤0.01%	1050
2021 Q2	$2K	Hold	21	–	–	﹤0.01%	966
2021 Q1	$2K	Buy	+21	New	+$2.76K	﹤0.01%	860

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPS Wealth Strategies Group's INO Position: Q4 2025 in Review

GPS Wealth Strategies Group held its Inovio Pharmaceuticals (INO) position steady in Q4 2025 at 4 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #582.

GPS Wealth Strategies Group first reported a position in INO in Q1 2021 and has held it in 19 quarters since. The position peaked at $2K in Q2 2021. 102 funds tracked by Wall St. Rank hold INO as of Q4 2025.

GPS Wealth Strategies Group held 4 shares of Inovio Pharmaceuticals worth $7 as of Q4 2025.
GPS Wealth Strategies Group left its Inovio Pharmaceuticals share count unchanged in Q4 2025.
Inovio Pharmaceuticals made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #582 holding.
GPS Wealth Strategies Group first reported a position in Inovio Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
GPS Wealth Strategies Group's Inovio Pharmaceuticals position peaked at $2K in Q2 2021.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.